Charles Schwab’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.5M Sell
1,506,075
-112,828
-7% -$1.17M ﹤0.01% 1997
2025
Q4
$20M Buy
1,618,903
+237,153
+17% +$2.54M ﹤0.01% 1747
2025
Q3
$12.2M Buy
1,381,750
+276,566
+25% +$2.15M ﹤0.01% 2020
2025
Q2
$7.05M Buy
1,105,184
+521,913
+89% +$2.99M ﹤0.01% 2176
2025
Q1
$2.83M Sell
583,271
-706,959
-55% -$5.85M ﹤0.01% 2506
2024
Q4
$12.3M Sell
1,290,230
-934,497
-42% -$8.58M ﹤0.01% 1920
2024
Q3
$18.6M Sell
2,224,727
-941,519
-30% -$8.56M ﹤0.01% 1731
2024
Q2
$21.6M Sell
3,166,246
-985,073
-24% -$4.24M ﹤0.01% 1629
2024
Q1
$10.5M Buy
4,151,319
+1,277,335
+44% +$2.88M ﹤0.01% 1961
2023
Q4
$6.9M Buy
2,873,984
+1,312,934
+84% +$3.09M ﹤0.01% 2177
2023
Q3
$5.31M Buy
1,561,050
+482,632
+45% +$2.68M ﹤0.01% 2226
2023
Q2
$7.93M Buy
1,078,418
+257,198
+31% +$2.38M ﹤0.01% 2016
2023
Q1
$8.51M Buy
821,220
+128,384
+19% +$1.55M ﹤0.01% 1948
2022
Q4
$8.18M Buy
692,836
+129,035
+23% +$2M ﹤0.01% 1974
2022
Q3
$11.8M Buy
563,801
+58,155
+12% +$1.62M ﹤0.01% 1731
2022
Q2
$15.7M Buy
505,646
+17,868
+4% +$610K 0.01% 1569
2022
Q1
$20M Buy
487,778
+18,113
+4% +$799K 0.01% 1553
2021
Q4
$20.4M Buy
469,665
+16,006
+4% +$724K 0.01% 1559
2021
Q3
$22.7M Sell
453,659
-83,282
-16% -$5.04M 0.01% 1480
2021
Q2
$33.8M Buy
536,941
+22,711
+4% +$1.46M 0.01% 1157
2021
Q1
$47.8M Sell
514,230
-85,856
-14% -$8.79M 0.02% 862
2020
Q4
$53.8M Sell
600,086
-7,826
-1% -$718K 0.02% 735
2020
Q3
$62.8M Buy
607,912
+141,726
+30% +$15.3M 0.03% 536
2020
Q2
$36.9M Sell
466,186
-39,083
-8% -$2.91M 0.02% 762
2020
Q1
$29.2M Buy
505,269
+5,609
+1% +$323K 0.02% 758
2019
Q4
$27M Buy
499,660
+21,637
+5% +$1.17M 0.01% 1006
2019
Q3
$25M Sell
478,023
-2,618
-0.5% -$122K 0.01% 996
2019
Q2
$23.2M Sell
480,641
-6,341
-1% -$304K 0.01% 1034
2019
Q1
$24.6M Buy
486,982
+50,728
+12% +$2.99M 0.02% 979
2018
Q4
$25.9M Sell
436,254
-23,130
-5% -$1.49M 0.02% 824
2018
Q3
$30.2M Buy
459,384
+22,141
+5% +$1.29M 0.02% 864
2018
Q2
$22.1M Sell
437,243
-9,348
-2% -$487K 0.02% 1005
2018
Q1
$23.5M Sell
446,591
-27,887
-6% -$1.39M 0.02% 897
2017
Q4
$22M Sell
474,478
-143,345
-23% -$6.03M 0.02% 918
2017
Q3
$25M Sell
617,823
-85,988
-12% -$3.11M 0.02% 759
2017
Q2
$23.9M Buy
703,811
+1,352
+0.2% +$41.7K 0.02% 734
2017
Q1
$20.4M Buy
702,459
+15,478
+2% +$471K 0.02% 821
2016
Q4
$22.6M Sell
686,981
-36,728
-5% -$1.1M 0.02% 682
2016
Q3
$22.8M Sell
723,709
-15,578
-2% -$453K 0.03% 611
2016
Q2
$20.8M Buy
739,287
+211,936
+40% +$8.31M 0.03% 613
2016
Q1
$19.2M Sell
527,351
-60,305
-10% -$2.13M 0.03% 625
2015
Q4
$23.5M Buy
587,656
+30,297
+5% +$1.06M 0.03% 533
2015
Q3
$15.9M Sell
557,359
-17,687
-3% -$583K 0.02% 666
2015
Q2
$18.9M Buy
575,046
+56,859
+11% +$1.76M 0.03% 603
2015
Q1
$14.9M Buy
518,187
+58,521
+13% +$1.68M 0.02% 734
2014
Q4
$12.5M Buy
459,666
+82,326
+22% +$1.96M 0.02% 747
2014
Q3
$8.04M Buy
377,340
+25,812
+7% +$591K 0.01% 989
2014
Q2
$7.9M Buy
351,528
+28,528
+9% +$664K 0.01% 1021
2014
Q1
$8.16M Buy
323,000
+79,485
+33% +$2.01M 0.01% 950
2013
Q4
$5.6M Buy
243,515
+116,469
+92% +$2.43M 0.01% 1161
2013
Q3
$2.47M Sell
127,046
-19,906
-14% -$355K 0.01% 1721
2013
Q2
$2.18M Buy
+146,952
New +$2.13M ﹤0.01% 1707

Other funds holding EBS